Vivos Therapeutics Inc (VVOS)
2.28
+0.02
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
2.28
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Profit Margin (Quarterly): -131.1% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -131.1% |
September 30, 2023 | -63.40% |
June 30, 2023 | -162.8% |
March 31, 2023 | -44.15% |
December 31, 2022 | -154.2% |
September 30, 2022 | -128.0% |
June 30, 2022 | -167.1% |
March 31, 2022 | -146.3% |
December 31, 2021 | -168.3% |
Date | Value |
---|---|
September 30, 2021 | -120.0% |
June 30, 2021 | -89.90% |
March 31, 2021 | -98.58% |
December 31, 2020 | -189.0% |
September 30, 2020 | -55.08% |
June 30, 2020 | -43.22% |
March 31, 2020 | -80.73% |
December 31, 2019 | -85.97% |
September 30, 2019 | -93.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-189.0%
Minimum
Dec 2020
-43.22%
Maximum
Jun 2020
-112.3%
Average
-109.3%
Median
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 10.76% |
Xtant Medical Holdings Inc | -15.79% |
Asensus Surgical Inc | -2.00K% |
Senseonics Holdings Inc | -374.0% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -473.0% |
Return on Assets | -103.5% |
Return on Invested Capital | -473.0% |
Gross Profit Margin (Quarterly) | 59.67% |
Operating Margin (Quarterly) | -131.9% |
Return on Net Operating Assets | -163.2% |